List view / Grid view
12 February 2014 | By The European Medicines Agency
The European Medicines Agency has introduced unique product identifiers (UPIs) to track medicines through pre-authorisation procedures...
12 February 2014 | By Pfizer
Pfizer agrees with the recommendation of the joint meeting of the FDA Arthritis Advisory Committee and Drug Safety and Risk Management Advisory Committee...
12 February 2014 | By AbbVie
AbbVie Inc. announces a US$320 million investment to establish operations in Singapore for small molecule and biologics active drug substance manufacturing...
11 February 2014 | By kdm communications
Scientists working at the Leibniz-Institute for Molecular Pharmacology (FMP) in Berlin, Germany, are benefitting from the low volume pipetting capability of a MultiChannel Arm™ (MCA) 384 for siRNA and small molecule screening...
11 February 2014 | By EMPERRA® GmbH
EMPERRA® GmbH E-Health Technologies announced the appointment of Dr. Christian Krey as Managing Director and CEO. Dr. Krey has many years of experience in the field of diabetes mellitus...
11 February 2014 | By The European Medicines Agency
The European Medicines Agency has clarified a number of points related to the new categories of variations to the terms of marketing authorisations that were introduced in August 2013. The related question and answer document has been updated to reflect these adjustments...
10 February 2014 | By The European Medicines Agency
The European Medicines Agency has published an update to its guidance for the annual strain change of influenza vaccines...
10 February 2014 | By kdm communications
Trinity Biotech is pleased to announce that its landmark, high sensitivity Meritas® Troponin I (TnI) point-of-care (POC) test has obtained CE marking...
10 February 2014 | By Merck
Merck and Samsung Bioepis Co., Ltd., announced that they have expanded their collaboration with an agreement to develop, manufacture and commercialize MK-1293...
7 February 2014 | By The European Medicines Agency
The European Medicines Agency reminds marketing authorisation holders that from 1 March 2014 the use of the eSubmission Gateway or web clientExternal link icon will become mandatory for all electronic Common Technical Document submissions...
7 February 2014 | By kdm communications
Cresset, Optibrium, Lhasa Limited and Chemogenomix, innovative providers of computational chemistry software and services, announce the ‘International Symposium on Compound Design Technologies: Guiding Better Decisions in Compound Design Technologies’...
7 February 2014 | By kdm communications
Quotient Clinical has commenced its 50th RapidFACT (Rapid Formulation development And Clinical Testing) program – a significant milestone in the development of this service...
6 February 2014 | By AstraZeneca
"As expected, our financial performance for 2013 reflects the ongoing impact from the loss of exclusivity for several key brands..."
5 February 2014 | By European Medicines Agency
A total of 11 out of 81 medicines recommended for marketing authorisation by the European Medicines Agency’s Committee for Medicinal Products for Human Use in 2013 were intended for the treatment of rare diseases...
5 February 2014 | By Pfizer
Agreement to combine Merck’s investigational anti-PD-1 and key Pfizer oncology assets...
